Eagle Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,927
Closed -$992K 561
2024
Q1
$992K Sell
2,927
-50
-2% -$16.4K 0.01% 505
2023
Q4
$961K Buy
2,977
+10
+0.3% +$3.13K 0.01% 484
2023
Q3
$1.06M Sell
2,967
-217
-7% -$83.7K 0.01% 470
2023
Q2
$1.21M Sell
3,184
-96
-3% -$39.1K 0.01% 463
2023
Q1
$1.57M Buy
3,280
+1,055
+47% +$494K 0.01% 453
2022
Q4
$939K Buy
2,225
+23
+1% +$9.28K 0.01% 475
2022
Q3
$918K Buy
2,202
+40
+2% +$19.9K 0.01% 481
2022
Q2
$1.07M Sell
2,162
-106
-5% -$55.2K 0.01% 487
2022
Q1
$1.28M Sell
2,268
-691
-23% -$417K 0.01% 498
2021
Q4
$2.24M Sell
2,959
-109
-4% -$81.6K 0.01% 480
2021
Q3
$2.29M Sell
3,068
-400
-12% -$300K 0.01% 469
2021
Q2
$2.23M Sell
3,468
-181
-5% -$110K 0.01% 470
2021
Q1
$2.12M Buy
3,649
+520
+17% +$308K 0.01% 471
2020
Q4
$1.82M Sell
3,129
-642
-17% -$366K 0.01% 431
2020
Q3
$1.94M Sell
3,771
-1,545
-29% -$783K 0.01% 445
2020
Q2
$2.3M Sell
5,316
-3,611
-40% -$1.59M 0.01% 435
2020
Q1
$3.13M Buy
8,927
+277
+3% +$102K 0.02% 411
2019
Q4
$3.2M Sell
8,650
-435
-5% -$153K 0.02% 467
2019
Q3
$3.02M Sell
9,085
-2,041
-18% -$666K 0.02% 472
2019
Q2
$3.48M Sell
11,126
-2,804
-20% -$840K 0.02% 446
2019
Q1
$4.26M Sell
13,930
-247
-2% -$66.7K 0.02% 431
2018
Q4
$3.29M Buy
14,177
+7,132
+101% +$1.91M 0.02% 439
2018
Q3
$2.21M Sell
7,045
-3,942
-36% -$1.22M 0.01% 516
2018
Q2
$3.17M Sell
10,987
-17,913
-62% -$4.95M 0.02% 477
2018
Q1
$7.23M Sell
28,900
-12,210
-30% -$3.11M 0.04% 364
2017
Q4
$9.86M Buy
41,110
+2,096
+5% +$508K 0.05% 322
2017
Q3
$8.69M Buy
39,014
+8,232
+27% +$1.85M 0.05% 346
2017
Q2
$6.97M Buy
30,782
+540
+2% +$118K 0.04% 374
2017
Q1
$6.03M Sell
30,242
-4,757
-14% -$916K 0.04% 395
2016
Q4
$6.38M Buy
34,999
+887
+3% +$151K 0.04% 372
2016
Q3
$5.59M Sell
34,112
-701
-2% -$106K 0.04% 390
2016
Q2
$4.98M Buy
34,813
+1,124
+3% +$160K 0.03% 407
2016
Q1
$4.61M Sell
33,689
-6,326
-16% -$830K 0.03% 417
2015
Q4
$5.55M Sell
40,015
-1,637
-4% -$227K 0.04% 395
2015
Q3
$5.59M Sell
41,652
-3,256
-7% -$469K 0.04% 397
2015
Q2
$6.76M Buy
44,908
+20,919
+87% +$2.99M 0.04% 386
2015
Q1
$3.24M Sell
23,989
-33,846
-59% -$4.2M 0.02% 471
2014
Q4
$6.97M Sell
57,835
-9,098
-14% -$1.05M 0.04% 381
2014
Q3
$7.59M Buy
66,933
+3,616
+6% +$428K 0.04% 367
2014
Q2
$7.58M Sell
63,317
-2,439
-4% -$298K 0.04% 384
2014
Q1
$8.42M Buy
65,756
+3,659
+6% +$469K 0.05% 381
2013
Q4
$7.67M Sell
62,097
-1,715
-3% -$209K 0.04% 346
2013
Q3
$7.46M Buy
63,812
+3,193
+5% +$377K 0.04% 418
2013
Q2
$6.8M Buy
+60,619
New +$7.11M 0.05% 407

Other funds holding BIO